Filter
557
Text search:
Cervical
cancer
and
HIV
Featured
81
184
Language
Document type
324
95
68
21
21
11
8
3
2
1
1
1
Countries / Regions
40
28
27
24
24
20
18
17
14
14
11
10
9
9
8
7
7
7
7
6
6
5
5
5
5
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
296
68
52
33
12
6
1
1
Toolboxes
88
26
15
13
11
11
9
7
7
5
4
4
4
3
2
2
1
1
1
1
1
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical
...
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of c
...
Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus
(HPV). In 2020, it was the fourth most common
...
This Plan envisions a future with the elimination of cervical cancer as a public health problem as a result of universal access to sexual health and
...
Cervical cancer is the fourth most common cancer in women worldwide in 2018, with 570,000 new cases and
...
The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing a
...
To identify and to assess factors enhancing or hindering the delivery of breast and cervical cancer
...
Contains many illustrations of all country materials – of risk factors, treatment procedures, side effects, coping, healthy lifestyle, and more; Promotes cancer screening, especially for breast
...
Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact
recommended
These guidelines focus on the collection and use of person-centred data across the HIV cascade – from prevention, testing and treatment to longer
...
This textbook seeks to support various levels of health personnel in less-resourced locations by providing evidence-based information about low-tech diagnostic and treatment options for common gynecological conditions such as
...
Cervical cancer, along with maternal deaths, has been identified as a national priority in
South Africa as well as other Sub-Saharan African countries. C
...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer p
...
Cervical intraepithelial neoplasia (CIN) is a premalignant lesion that may exist at any one of three stages: CIN1, CIN2, or CIN3. If left untreated, CIN2 or CIN3 (collectively referred to as CIN2+) can progress to
...
This WHO Guidance Note advocates for a comprehensive approach to cervical cancer prevention and control
...
Cervical cancer is the second most common cancer among women worldwide and causes a sig
...
Background: Cervical cancer accounts for 23% of cancer incidence and 22% of
...
PLoS ONE 18(5): e0285031. https://doi.org/10.1371/journal.pone.0285031
The study aims to integrate HPV vaccination into routine care in adolescent HIV clinics. To achieve success, we will co-design a package of implementation strategies using a pre
...
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. In particular, it outlines
...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affect
...
